2,6-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 2.5g

TERT-BUTYL 8-FORMYL-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE, 95.0%, 1g

3-BROMO-6-CHLORO-1H-PYRAZOLO[4,3-C]PYRIDINE, 95%, 1g

5-bromo-1H-pyrazole-4-carbonitrile, 95%, 10g

4-(Methylsulfonyl)-2-nitrobenzoic acid, 95.0%, 25g

Boc-2-bromo-L-phenylalanine, 95.0%, 100g

4-(2-(Piperidin-1-yl)ethoxy)benzaldehyde, 98%, 1g

{[2-(1-pyrrolidinyl)ethyl]thio}acetic acid hydrochloride, 95.0%, 5g

5-CHLORO-6-FLUOROPYRIDIN-3-YLBORONIC ACID, 92.0%, 1g

6-(Cyclohexylmethoxy)-9H-purin-2-amine, 95.0%, 1g

6-Bromo-8-aminoquinaldine, 97%, 100mg

GC capillary column ROTI®Cap-5, 10 m, 0.25 mm, 0.25 µm, 1 Piece(s)

D-gluconic acid calcium salt monohydrate, min. 98.5%, Ph. Eur., 1 kg, plastic packaging.